Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2011, Vol. 16 ›› Issue (5): 558-562.

Previous Articles     Next Articles

Compare study of clinical features in polymyositis and dermatomyositis

XUAN Dan, SHENG Jun, LI Zhi , MAO Tong-jun, XU Liang , LU Jin-ming   

  1. Department of Rheumatology,Yijishan Hospital of Wannan Medical College, Wuhu 241000, Anhui, China
  • Received:2011-03-07 Revised:2011-04-12 Published:2011-07-08

Abstract: AIM: To study the difference of clinical charactertics between polymyositis and dermatomyositis patients.METHODS: 11 cases of polymyositis and 21 cases of dermatomyositis were included in this study.Their muscle strength, serum creatine phosphokinase (CPK) levels, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), hospitalization times, the quadriceps muscle MRI and high-resolution lung CT (HRCT) were compared.RESULTS: There were no statistic differences among muscle strength, ESR, CRP, hospitalization times, hoarseness and dysphagia in the two groups(P>0.05).The level of CPK in polymyositis patients was significantly higher than that in dermatomyositis patients [(3032±2973)vs(390±947) U/L(P=0.015)]. But the rate of incidence of interstitial pneumoniin in dermatomyositis patients was significantly higher than that in polymyositis patients (P=0.021),and the therapy effect of glucocorticoids in polymyositis patients was significantly better than that in dermatomyositis patients (P=0.013). 4 deaths were all dermatomyositis patients,3 cases died with interstitial pneumoniin developed respiratory failure and 1 cases died with rhabdomyolysis developed acute renal failure.CONCLUSION: The level of CPK in dermatomyositis patients is higher than polymyositis patients, but more complicated that in by interstitial pneumoniin and poor prognosis.

Key words: Polymyositis, Ermatomyositis, Prognosis

CLC Number: